Key Highlights

  • Cenntro (NASDAQ:CENN) fell 46.02% to USD 0.1607, with a USD 100 million share program as the main overhang.
  • INLIF (NASDAQ:INLF) dropped 11.83% to USD 0.2981, and its warrants carry price reset terms.
  • Wellchange (NASDAQ:WCT) slipped 7.54% to USD 0.2538, following a filing that covers up to 50 million shares.
  • Lakewood-Amedex (NASDAQ:LABT) declined 7.69% to USD 0.18, with convertible preferred stock outstanding.
  • Abits Group (NASDAQ:ABTS) lost 9.78% to USD 0.3609, after a USD 250 million Equity line became effective.

Cenntro (NASDAQ:CENN) (down USD 0.1370, 46.02%): A Delivery Update Arrives Alongside a Large Share Program

Cenntro (NASDAQ:CENN) fell 46.02% to USD 0.1607 in pre-market trading on November 4, 2026. The only announcement identified, dated November 3, 2026, said 20 LS450 electric trucks were delivered under a New York voucher program, representing more than USD 2.44 million in revenue. No filing explaining the decline was found, so the cause remains unconfirmed.

The backdrop includes a sales agreement dated October 9, 2026 that allows up to USD 100 million of common stock to be offered over time, while the Market Value was only about USD 7.4 million in mid October. Full year 2025 net loss was about USD 72.98 million, and the share price is again far below USD 1.00, so a Nasdaq notice is a risk.

INLIF (NASDAQ:INLF) (down USD 0.0400, 11.83%): Warrant Resets Sit Behind the Slide

INLIF (NASDAQ:INLF) fell 11.83% to USD 0.2981 in pre-market trading on November 4, 2026. No company announcement dated November 2, 3 or 4, 2026 was identified. The October offering raised about USD 3.75 million at USD 1.60.

Series A and B warrants carry a one-time downward reset in mid November 2026 (calculated), while Series C warrants depend on a price adjustment that ended around November 3, 2026 (calculated). The outcome is undisclosed, so any link to the move is an inference. First half 2026 Revenue was USD 12.94 million with Net Income of USD 1.01 million, yet the filing showed 30,458,162 Class A shares if all warrants were exercised.

Wellchange (NASDAQ:WCT) (down USD 0.0207, 7.54%): Thin Float Meets a 50 Million Share Filing

Wellchange (NASDAQ:WCT) fell 7.54% to USD 0.2538 in pre-market trading on November 4, 2026. No company release or filing dated November 2 to November 4, 2026 was identified as a catalyst. The price sits about 64% below the USD 0.7001 close of October 12, 2026 (calculated), a level reached after a 28.29% one-day drop.

The main overhang is an August 11, 2026 filing covering up to 50 million Class A shares at an assumed USD 0.16, which would lift shares outstanding from 2,905,328 to 52,905,328 if fully placed. Revenue for 2025 fell 41.6% to USD 1.35 million, and the net loss was USD 7.32 million. A 400 for 1 share consolidation was not confirmed as effective.

Lakewood-Amedex (NASDAQ:LABT) (down USD 0.0150, 7.69%): Convertible Preferred Weighs on a Clinical Story

Lakewood-Amedex (NASDAQ:LABT) fell 7.69% to USD 0.18 in pre-market trading on November 4, 2026. No release or filing dated November 2 to November 4, 2026 was identified as the cause. The shares dropped 19.31% on October 21, 2026, the day laboratory data on its Nu-3 gel were released.

The company completed a USD 7.5 million Series C preferred placement. The 451,240 Preferred Shares still outstanding could convert into up to 4,512,400 common shares, subject to a 4.99% ownership cap. A reverse split of up to 1 for 20 was also proposed, but the vote outcome and current cash were not identified. Topline Phase 2a data are guided for early 2027.

Abits Group (NASDAQ:ABTS) (down USD 0.0391, 9.78%): Equity Line Registration Hangs Over an AI Plan

Abits Group (NASDAQ:ABTS) fell 9.78% to USD 0.3609 in pre-market trading on November 4, 2026, from an implied prior close of about USD 0.40 (calculated). The company has not stated a cause. A registration tied to a potential USD 250 million equity line became effective on November 2, 2026, and the agreement carries a USD 7.5 million commitment fee payable in shares or pre-funded warrants.

On November 3, 2026, when the stock fell 65.00% in regular trading, the company announced a phased evaluation of AI hosting, noting that no definitive agreements were signed. Roughly 3.2 million shares outstanding (calculated from earlier screen data), so the Facility is very large by comparison. 2025 revenue was USD 9.13 million with a net loss of USD 2.87 million.

Where Things Stand

All five are penny stocks where the financing structure, rather than an operating headline, is the common thread. Cenntro (NASDAQ:CENN) has a large share program, INLIF (NASDAQ:INLF) has warrant resets, Wellchange (NASDAQ:WCT) has a registered share filing, Lakewood-Amedex (NASDAQ:LABT) has convertible preferred stock and Abits Group (NASDAQ:ABTS) has an effective equity line. Investors should watch for disclosures of actual share issuance, Nasdaq minimum bid notices and quarterly reports.